Shanghai Kindly Enterprise Development Group (603987) Fair Value & Analysis
Healthcare · CN · Market cap 3.2B CNY
Fair value as of: Jul 12, 2026
From 26 valuation models · updated 29 days ago
Fair value updated Jul 12, 2026, revised from ¥12.11 to ¥11.20 (−7.5%) since Jun 24, 2026. Share price +3.3% over the past month.
A solid business, screening 51% undervalued on our models.
What matters now
- The price is below even our cautious bear case (¥8.36). The market is more pessimistic than our downside scenario.
- Solid quality (65/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 12, 2026.
How to read this chart
60‑month range ¥5.82 – ¥30.06 · fair‑value band ¥8.36 – ¥14.03 · the ¥7.42 price screens below the ¥11.20 fair value. Dashed = 300-day average. As of Jul 12, 2026.
Analysis
Shanghai Kindly Enterprise Development Group (603987) currently trades at ¥7.42, while our model-based Fair Value estimate is ¥11.20, implying the stock looks roughly 50.9% undervalued today. The Quality Score stands at 65/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Shanghai Kindly Enterprise Development Group generated revenue of 2.3B CNY at a net margin of 10.2%. Revenue declined 2.1% year over year. It earns a return on equity of 8.3%. Net debt stands at 57.4M CNY. Fundamentals as of Jul 12, 2026
Our scenario range runs from ¥8.36 (bear case) to ¥14.03 (bull case); at ¥7.42, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 27% below its 52-week high and 7% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -43% fair-value upside, at 51%, 603987 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (¥10.65) versus Dividend Discount (¥2.66). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 64 · Market factors (momentum, volatility) 41
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Shanghai Kindly Enterprise Development Group Co.,LTD. researches, develops, produces, sales medical devices such as medical puncture needles and medical infusion devices worldwide. It offers syringes, infusion sets, needles, and tube bags.
Full company description
Shanghai Kindly Enterprise Development Group Co.,LTD. researches, develops, produces, sales medical devices such as medical puncture needles and medical infusion devices worldwide. It offers syringes, infusion sets, needles, and tube bags. The company also provides including medical packing films, sterilization indicator tapes and needles; and intervention accessories, such as stopcocks. In addition, it offers disposable coaxial biopsy needle, therapy device, disposable pump infusion sets, drug liquid transfer devices, needle-proof prefilled syringe assemblies, polypropylene prefilled injection, disposable water delivery tube, disposable anti-needle injection and pen needle, micro needle, disposable skin-penetrating guide needles and syringes, radiofrequency treatment puncture needle, visual double-lumen endotracheal tube, disposable reflux indwelling needle, root irrigation needle, disposable arterial blood gas needle, compression hemostatic device. Further, it offers puncture care, infusion catheters, indwelling infusions, puncture intervention, medical beauty, and medicine bags. The company was founded in 1987 and is headquartered in Shanghai, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Shanghai Kindly Enterprise Development Group reported revenue of ¥2.3B in FY2025 versus ¥3.1B in FY2021, a compound −7.2%/yr. Reported net income was ¥240M in FY2025, compounding −4.7%/yr from FY2021.
Watch 603987: get an alert when its fair value changes →
Peer Group
Medical Instruments & Supplies · 203 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $402.33 | $150.04 | -63% |
| EssilorLuxottica Société anonyme 1EL | €172.45 | €68.55 | -60% |
| Medline Inc MDLN | $41.11 | $30.15 | -27% |
| Becton, Dickinson and Company BDX | $150.65 | $103.53 | -31% |
| Alcon Inc ALC | $70.26 | $39.78 | -43% |
| ResMed Inc RMD | $203.87 | $187.89 | -8% |
| West Pharmaceutical Services, Inc WST | $353.71 | $143.97 | -59% |
| Straumann Holding STMN | CHF 106.00 | CHF 47.31 | -55% |
| Sartorius Stedim Biotech S.A DIM | €188.50 | €51.16 | -73% |
| Coloplast A/S COLOB | kr 414.00 | kr 382.22 | -8% |
Compare Shanghai Kindly Enterprise Development Group with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Shanghai Kindly Enterprise Development Group (603987) overvalued or undervalued?
What is the fair value of 603987?
What is the quality score of 603987?
What is the revenue of Shanghai Kindly Enterprise Development Group (603987)?
What is the net profit margin of 603987?
Does Shanghai Kindly Enterprise Development Group pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Shanghai Kindly Enterprise Development Group and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.